Joel Greenblatt - Gotham Asset Management
Holding/activity history for Progenics Pharmaceuticals In (PGNX)
← All PGNX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2017 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2017 Q3 | 33,737 | <0.01 | Reduce 89.02% | 0.03 | $7.35 | $248,000 | SEC |
| 2017 Q2 | 307,393 | 0.03 | Reduce 54.58% | 0.05 | $6.79 | $2,087,000 | SEC |
| 2017 Q1 | 676,791 | 0.08 | Add 27.79% | 0.02 | $9.44 | $6,389,000 | SEC |
| 2016 Q4 | 529,614 | 0.06 | Add 983.65% | 0.05 | $8.64 | $4,576,000 | SEC |
| 2016 Q3 | 48,873 | <0.01 | Buy | <0.01 | $6.32 | $309,000 | SEC |